EA000877B1 - Способ получения ингибиторов фосфодиэстеразы iv - Google Patents
Способ получения ингибиторов фосфодиэстеразы iv Download PDFInfo
- Publication number
- EA000877B1 EA000877B1 EA199800931A EA199800931A EA000877B1 EA 000877 B1 EA000877 B1 EA 000877B1 EA 199800931 A EA199800931 A EA 199800931A EA 199800931 A EA199800931 A EA 199800931A EA 000877 B1 EA000877 B1 EA 000877B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- alkenyl
- alkyl
- phenyl
- compound
- znmgbr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- C07D213/34—Sulfur atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1568796P | 1996-04-17 | 1996-04-17 | |
| GBGB9612083.7A GB9612083D0 (en) | 1996-06-10 | 1996-06-10 | Method of preparing phosphodiesterase IV inhibitors |
| PCT/US1997/006131 WO1997038976A1 (en) | 1996-04-17 | 1997-04-14 | Method of preparing phosphodiesterase iv inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA199800931A1 EA199800931A1 (ru) | 1999-04-29 |
| EA000877B1 true EA000877B1 (ru) | 2000-06-26 |
Family
ID=26309476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA199800931A EA000877B1 (ru) | 1996-04-17 | 1997-04-14 | Способ получения ингибиторов фосфодиэстеразы iv |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0898564A1 (pt) |
| CN (1) | CN1216532A (pt) |
| AR (1) | AR006550A1 (pt) |
| AU (1) | AU2459297A (pt) |
| BR (1) | BR9708684A (pt) |
| CZ (1) | CZ333298A3 (pt) |
| EA (1) | EA000877B1 (pt) |
| SK (1) | SK143198A3 (pt) |
| TW (1) | TW426669B (pt) |
| WO (1) | WO1997038976A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW508353B (en) * | 1996-09-17 | 2002-11-01 | Merck & Co Inc | Method of preparing phosphodiesterase IV inhibitors |
| WO1998012178A1 (en) * | 1996-09-17 | 1998-03-26 | Merck & Co., Inc. | Method of preparing phosphodiesterase iv inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW263495B (pt) * | 1992-12-23 | 1995-11-21 | Celltech Ltd | |
| GB9326173D0 (en) * | 1993-12-22 | 1994-02-23 | Celltech Ltd | Chemical compounds and process |
-
1997
- 1997-04-07 AR ARP970101372A patent/AR006550A1/es unknown
- 1997-04-14 BR BR9708684A patent/BR9708684A/pt unknown
- 1997-04-14 CZ CZ983332A patent/CZ333298A3/cs unknown
- 1997-04-14 AU AU24592/97A patent/AU2459297A/en not_active Abandoned
- 1997-04-14 EP EP97920379A patent/EP0898564A1/en not_active Withdrawn
- 1997-04-14 CN CN97193932A patent/CN1216532A/zh active Pending
- 1997-04-14 WO PCT/US1997/006131 patent/WO1997038976A1/en not_active Ceased
- 1997-04-14 EA EA199800931A patent/EA000877B1/ru not_active IP Right Cessation
- 1997-04-14 SK SK1431-98A patent/SK143198A3/sk unknown
- 1997-04-15 TW TW086104869A patent/TW426669B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997038976A1 (en) | 1997-10-23 |
| SK143198A3 (en) | 1999-06-11 |
| TW426669B (en) | 2001-03-21 |
| AU2459297A (en) | 1997-11-07 |
| CZ333298A3 (cs) | 1999-03-17 |
| CN1216532A (zh) | 1999-05-12 |
| EA199800931A1 (ru) | 1999-04-29 |
| BR9708684A (pt) | 1999-08-03 |
| EP0898564A1 (en) | 1999-03-03 |
| AR006550A1 (es) | 1999-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4613610A (en) | Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives | |
| EP0244364A2 (en) | Preparation of olefinic compounds | |
| EP3753926B1 (en) | Spiro compound as indoleamine-2,3-dioxygenase inhibitor | |
| EP0265640A2 (en) | Azaindole and indolizine derivatives, processes for their production and their use as pharmaceuticals | |
| US5541329A (en) | Intermediates prepared in an asymmetric total synthesis of camptothecin analogs | |
| US4822799A (en) | Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals | |
| EP1189890B1 (fr) | Dihydrobenzodiazepines et leur utilisation dans le traitement de dyslipidemies | |
| US4939159A (en) | Azaindole derivatives useful as cholesterol biosynthesis inhibitors | |
| EP0111997A2 (en) | Vinyl carboxylic acid derivatives, their production and use | |
| CZ305964B6 (cs) | Způsob syntézy prostaglandinů | |
| EA000877B1 (ru) | Способ получения ингибиторов фосфодиэстеразы iv | |
| US5346912A (en) | 2-cyano-3-hydroxy-(n-pyridyl)-propenamide compounds | |
| WO2009024323A2 (en) | Process for preparing pyrimidine derivatives | |
| CA3132365A1 (en) | Novel synthetic options towards the manufacture of (6r,10s)-10- {4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)- pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7 8,9,10-hexahydro-11,15-(metheno)pyrazolo [4,3-b][1,7]diazacyclotetradecin-5(6h)-one | |
| US5554764A (en) | Preparation of pyrrol and oxazole compounds: formation of C-acyl-α-amino acid esters therefrom | |
| US5728838A (en) | Method of preparing phosphodiesterase IV inhibitors | |
| EP2084125B1 (fr) | Derives d'aminobenzocycloheptene, leurs procedes de preparation et leur utilisation en therapeutique | |
| US4755612A (en) | Intermediate compounds resulting from method for forming a dihydrogen-phosphate inositol | |
| EP0300249A1 (de) | 7-[1H-Pyrrol-3-yl]-substituierte 3,5-Dihydroxy-heptansäuren, ihre entsprechenden delta-Lactone und Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel, pharmazeutische Präparate und Zwischenprodukte | |
| TWI870909B (zh) | 用於製備奈瑪特韋(nirmatrelvir)之方法及中間體 | |
| RU2260001C2 (ru) | Способ получения 7-хинолинил-3,5-дигидроксигепт-6-еноата | |
| WO1998031671A1 (fr) | Derives de pyridone, leur preparation et leur utilisation comme intermediaires de synthese | |
| KR20000026291A (ko) | 캐테콜 히드라진 유도체, 이의 제조 방법 및 이를 함유한 약제학적 조성물 | |
| US4973704A (en) | Pyrrolyl intermediates in the synthesis of pyrrole analogs of mevalonolactone and derivatives thereof | |
| Cossy et al. | Radical Cyclizations–Synthesis of γ‐Lycorane |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |